IN THIS
ISSUE
INTERVIEW WITH
BILCARE INC., USA’S
PRESIDENT & GLOBAL COO
MR. STEVEN
JACOBS
Specialty Devices
38
Chris Halling, MCIM
Lifecycle
Strategies
42
Jason McKinnie, MPH
Protein
Production
R.P. Patel, MPharm
47
FEATURING
CROs &
Specialty Pharma
68
The science & business of specialty pharma, biotechnology, and drug delivery
Market
Indices
Josef Bossart, PhD
79
Thomas M.
Parkinson,
PhD
Hybresis TTMM: The
Hybridization of
Traditional With
Low-Voltage
Iontophoresis
Clifford
Davidson,
Esq.
Product-By-Process
Claims: Different
Interpretations in
Different Settings?
Cindy H.
Dubin
Systemiic
Pullmonary
Delliivery: One Year
Afftter Exubera''s
Approval
Japanese
Competition
Keith Morton, MBA
